← Back
Data updated: Mar 10, 2026
PAI HOLDINGS PHARM
DermatologyInfectious DiseaseNeurology
PAI HOLDINGS PHARM is a major pharmaceutical company focused on Dermatology, Infectious Disease, Neurology. Key products include VANCOMYCIN HYDROCHLORIDE.
1951
Since
45
Drugs
-
Trials
388
Approved (2yr)
Recent Activity
GABAPENTIN 2026-02-24
Labeling
GABAPENTIN 2026-02-18
Labeling
GABAPENTIN 2026-02-17
Labeling
GABAPENTIN 2026-02-17
Labeling
GABAPENTIN 2026-02-12
Labeling
NYSTATIN 2026-02-05
GABAPENTIN 2026-01-29
Labeling
GABAPENTIN 2026-01-29
Labeling
PROPRANOLOL HYDROCHLORIDE 2026-01-27
GABAPENTIN 2026-01-14
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 40%
4 drugs
Infectious Disease 20%
2 drugs
Neurology 20%
2 drugs
Cardiovascular 10%
1 drugs
Immunology 10%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Infectious Disease, Dermatology, Immunology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Immunology
BAUSCH AND LOMB specialty
Cardiovascular, Infectious Disease, Dermatology, Immunology
Merck big-pharma
Infectious Disease, Cardiovascular, Immunology
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
Active (16)
SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE OXCARBAZEPINE PROMETHAZINE DM DESOXIMETASONE DICLOFENAC SODIUM PHENYTOIN LOPERAMIDE HYDROCHLORIDE CLINDAMYCIN PHOSPHATE VANCOMYCIN HYDROCHLORIDE CEFOTAN IBUPROFEN SODIUM POLYSTYRENE SULFONATE NYSTATIN FLUOCINONIDE ERYTHROMYCIN PROPRANOLOL HYDROCHLORIDE
Discontinued (29)
GABAPENTIN ACETAMINOPHEN AND CODEINE PHOSPHATE HYDROXYZINE HYDROCHLORIDE CLOBETASOL PROPIONATE TRIAMCINOLONE ACETONIDE LIDOCAINE HYDROCHLORIDE FLUOCINOLONE ACETONIDE LACTULOSE VALPROIC ACID LIDOCAINE AND PRILOCAINE MIDAZOLAM HYDROCHLORIDE CIMETIDINE HYDROCHLORIDE ATOVAQUONE LITHIUM CITRATE LIDOCAINE HYDROCHLORIDE VISCOUS DESONIDE NYSTATIN AND TRIAMCINOLONE ACETONIDE ZINACEF ZINACEF IN PLASTIC CONTAINER FORTAZ AQUAMEPHYTON FORTAZ IN PLASTIC CONTAINER ZANTAC IN PLASTIC CONTAINER ZANTAC NORFLEX DEXCHLORPHENIRAMINE MALEATE TENSILON TENSILON PRESERVATIVE FREE CEFOTAN IN PLASTIC CONTAINER
Company Info
- First Approval
- 1951-05-03
- Latest
- 2025-12-22
- Applications
- 52
FDA Sponsor Names
PAI HOLDINGS PHARMPAI HOLDINGS